Effects of IκBα and its mutants on NF-κB and p53 signaling pathways

World Journal of Gastroenterology

Volumn 12, Issue 41, 2006, Pages 6658-6664

  Li, Xian ^a   Xing, Da ^a   Wang, Ju ^b   Zhu, De Bin ^a   Zhang, Lan ^a   Chen, Xiao Jia ^b   Sun, Fen Young ^b   Hong, An ^b  

^a SOUTH CHINA NORMAL UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

Inhibitor of NF B alpha; Nuclear factor B; p53; Real time QT PCR

Indexed keywords

BETA ACTIN; CHOLECYSTOKININ OCTAPEPTIDE; COMPLEMENTARY DNA; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MUTANT PROTEIN; PROTEIN BAX; PROTEIN P53; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA; YELLOW FLUORESCENT PROTEIN; FLUORESCENT DYE; FLUORESCENT PROTEIN 583; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PHOTOPROTEIN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; ENZYME PHOSPHORYLATION; GENE TARGETING; LASER MICROSCOPY; NUCLEOTIDE SEQUENCE; PLASMID; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; CELL CULTURE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MUTATION; PHYSIOLOGY; PROTEIN BINDING;

APOPTOSIS; FLUORESCENT DYES; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; LUMINESCENT PROTEINS; MUTATION; NF-KAPPA B; PROTEIN BINDING; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33751287346     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i41.6658     Document Type: Article

References (40)

1. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986; 46: 705-716
2. May MJ, Ghosh S. Rel/NF-kappa B and I kappa B proteins: an overview. Semin Cancer Biol 1997; 8: 63-73
3. Gong JP, Liu CA, Wu CX, Li SW, Shi YJ, Li XH. Nuclear factor kB activity in patients with acute severe cholangitis. World J Gastroenterol 2002; 8: 346-349
4. Tu B, Gong JP, Feng HY, Wu CX, Shi YJ, Li XH, Peng Y, Liu CA, Li SW. Role of NF-kB in multiple organ dysfunction during acute obstructive cholangitis. World J Gastroenterol 2003; 9: 179-183
5. Joyce D, Albanese C, Steer J, Fu M, Bouzahzah B, Pestell RG. NF-kappaB and cell-cycle regulation: the cyclin connection. Cytokine Growth Factor Rev 2001; 12: 73-90
6. Jacobs MD, Harrison SC. Structure of an IkappaBalpha/NF-kappaB complex. Cell 1998; 95: 749-758
7. Huguet C, Crepieux P, Laudet V. Rel/NF-kappa B transcription factors and I kappa B inhibitors: evolution from a unique common ancestor. Oncogene 1997; 15: 2965-2974
8. Whiteside ST, Israel A. I kappa B proteins: structure, function and regulation. Semin Cancer Biol 1997; 8: 75-82
9. Yamamoto Y, Gaynor RB. IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem Sci 2004; 29: 72-79
10. Brockman JA, Scherer DC, Mckinsey TA, Hall SM, Qi X, Lee WY, Ballard DW. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol Cell Biol 1995; 15: 2809-2818
11. Yang L, Chen H, Qwarnstrom E. Degradation of IkappaBalpha is limited by a postphosphorylation/ubiquitination event. Biochem Biophys Res Commun 2001; 285: 603-608
12. Dejardin E, Deregowski V, Chapelier M, Jacobs N, Gielen J, Merville MP, Bours V. Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells. Oncogene 1999; 18: 2567-2577
13. Wulczyn FG, Krappmann D, Scheidereit C. Signal-dependent degradation of IκBα is mediated by an inducible destruction box that can be transferred to NF-κB, Bcl-3 or p53. Nucleic Acids Res 1998; 26: 1724-1730
14. Traenckner EB, Wilk S, Baeuerle PA. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J 1994; 13: 5433-5441
15. Renard P, Percherancier Y, Kroll M, Thomas D, Virelizier JL, Arenzana-Seisdedos F, Bacheleriel F. Inducible NF-kappa B activation is permitted by simultaneous degradation of nuclear I kappa B alpha. J Biol Chem 2000; 275: 15193-15199
16. Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ. The nuclear factor-κB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 1999; 5: 119-127
17. Wood KM, Roff M, Hay RT. Defective IkappaBalpha in Hodgkin cell lines with constitutively active NF-kappaB. Oncogene 1998; 16: 2131-2139
18. Lin A, Karin M. NF-kappaB in cancer: a marked target. Semin Cancer Biol 2003; 13: 107-114
19. Perkins ND. NF-kappaB: tumor promoter or suppressor? Trends Cell Biol 2004; 14: 64-69
20. Fujioka S, Sclabas GM, Schmidt C, Niu J, Frederick WA, Dong QG, Abbruzzese JL, Evans DB, Baker C, Chiao PJ. Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis. Oncogene 2003; 22: 1365-1370
21. Huang S, Pettaway CA, Uehara H, Bucana CD, Fidler IJ. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 2001; 20: 4188-4197
22. Huang S, Robinson JB, Deguzman A, Bucana CD, Fidler IJ. Blockade of nuclear factor-κB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res 2000; 60: 5334-5339
23. Chang NS. The non-ankyrin C terminus of IκBα physically interacts with p53 in vivo and dissociates in response to apoptotic stresss, hypoxia, DNA damage, and transforming growth factor-β1-mediated growth suppression. J Biol Chem 2002; 277: 10323-10331
24. Schmid JA, Birbach A, Hofer-Warbinek R, Pengg M, Burner U, Furtmüller PG, Binder BR, Martin RD. Dynamics of NF-κB and IκBα studied with green fluorescent protein (GFP) fusion proteins. J Biol Chem 2000; 275: 17035-17042
25. Tsuruta F, Masuyama N, Gotoh Y. The Phosphatidylinositol 3-Kinase (PI3K)-Akt Pathway Suppresses Bax Translocation to Mitochondria. J Biol Chem 2002; 277: 14040-14047
26. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999; 18: 6853-6866
27. Chang YC, Lee YS, Tejima T, Tanaka K, Omura S, Heintz NH, Mitsui Y, Magae J. Mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway. Cell Growth Differ 1998; 19: 179-184
28. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: 2002-2007
29. Harris CC. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 1996; 88: 1442-1455
30. Walker KK, Levine AJ. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. PNAS 1996; 93: 15335-15340
31. Simeonidis S, Stauber D, Chen GY, Hendrickson WA, Thanos D. Mechanisms by which IκB proteins control NF-κB activity. PNAS 1999; 96: 49-54
32. Malek S, Huxford T, Ghosh G. IκBα Functions through direct contacts with the nuclear localization signals and the DNA binding sequences of NF-κB. J Biol Chem 1998; 273: 25427-25435
33. Arenzana-Seisdedos F, Turpin P, Rodriguez M, Thomas D, Hay RT, Virelizier JL, Dargemont C. Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J Cell Sci 1997; 110: 369-378
34. Zhou M, Gu L, Zhu N, Woods WG, Findley HW. Transfection of a dominant-negative mutant NF-kB inhibitor (IkBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells: interaction of IkBm. and p53. Oncogene 2003; 22: 8137-8144
35. Bentires-Alj M, Hellin AC, Ameyar M, Chouaib S, Merville MP, Bours V. Stable inhibition of nuclear factor κB in cancer cells does not increase sensitivity to cytotoxic drugs. Cancer Res 1999; 59: 811-815
36. Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, Wu T, Tsao MS, Evans DB, Abbruzzese JL, McDonnell TJ, Chiao PJ. The function of multiple IkappaB: NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis. Oncogene 2002; 21: 6510-6519
37. Fujioka S, Schmid C, Sclabas GM, Li ZK, Pelicano H, Peng B, Yao A, Niu J, Zhang W, Evans DB, Abbruzzese JL, Huang P, Chiao PJ. Stabilization of p53 is a novel mechanism for proapoptotic function of NF-κB. J Biol Chem 2004; 279: 27549-27559
38. Ryan KM, Ernst MK, Rice NR, Vousden KH. Role of NF-kappaB in p53-mediated programmed cell death. Nature 2000; 404: 892-897
39. Aleyasin H, Cregan SP, Iyirhiaro G, O'Hare MJ, Callaghan SM, Slack RS, Park DS. Nuclear factor-κB modulates the p53 response in neurons exposed to DNA damage. J Neurosci 2004; 24: 2963-2973
40. Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002; 2: 301-310